简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Rare Earth ETF
Rare Earth and Minor Metal Prices Continue to Rise;Huatai-PB CSI Rare earth industry ETF (516780) Gains 2.01% in Early Trading
Tags:
ETF
516780.SH
Rare Earth ETF
2026-02-27
Widening Supply-Demand Gap Boosts Market Confidence,Rare Earth ETF(159713) Rises 1.80% Intraday
Tags:
ETF
159713.SZ
Rare Earth ETF
2026-01-28
Institution: Dual Improvement in Strategic Status and Profitability,Rare Earth ETF(159713) Rises 2.71% Intraday
Tags:
ETF
159713.SZ
Rare Earth ETF
2026-01-23
Rare Earth Downstream Rigid Demand Support Remains Strong,Huatai-PB CSI Rare earth industry ETF(516780) Up Nearly 4%
Tags:
ETF
Rare Earth ETF
516780.SH
2026-01-12
Rare Earth Permanent Magnet Industry at New Cycle Starting Point, Huatai-PB CSI Rare earth industry ETF (516780) Surges Over 4% in Morning Trading
Tags:
Rare Earth ETF
ETF
516780.SH
2026-01-09
Huatai-PB CSI Rare earth industry ETF(516780) Up 1.67% in Morning Trading
Tags:
Rare Earth ETF
516780.SH
ETF
2026-01-07
Huatai-PB CSI Rare earth industry ETF (516780) Rises 1.94%, Aiming for Eighth Consecutive Gain
Tags:
Rare Earth ETF
516780.SH
ETF
2026-01-06
Featured News
Finance
Estun (02715.HK): Positive Profit Forecast, Interim Net Profit Attributable to Parent Expected to Surge Around 21 to 26 Times
Finance
CHINA DEVELOPMENT BANK FINANCIAL LEASING(01606.HK): Acquisition of Three Vessels at Consideration Not Exceeding USD 138 Million
Finance
Holly Futures(03678.HK): Independent Director Zhang Hongfa Resigns
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Scan QR Code
Download App